0001209191-23-059337.txt : 20231220
0001209191-23-059337.hdr.sgml : 20231220
20231220162201
ACCESSION NUMBER: 0001209191-23-059337
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20231113
FILED AS OF DATE: 20231220
DATE AS OF CHANGE: 20231220
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: 22NW Fund, LP
CENTRAL INDEX KEY: 0001640809
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40388
FILM NUMBER: 231501543
BUSINESS ADDRESS:
STREET 1: 1455 NW LEARY WAY
STREET 2: SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98107
BUSINESS PHONE: 206-227-3078
MAIL ADDRESS:
STREET 1: 1455 NW LEARY WAY
STREET 2: SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98107
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: 22NW, LP
CENTRAL INDEX KEY: 0001694297
ORGANIZATION NAME:
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40388
FILM NUMBER: 231501544
BUSINESS ADDRESS:
STREET 1: 590 1ST AVE S, UNIT C1
CITY: SEATTLE
STATE: WA
ZIP: 98104
BUSINESS PHONE: 206-437-9174
MAIL ADDRESS:
STREET 1: 590 1ST AVE S, UNIT C1
CITY: SEATTLE
STATE: WA
ZIP: 98104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: English Aron R.
CENTRAL INDEX KEY: 0001770436
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40388
FILM NUMBER: 231501545
MAIL ADDRESS:
STREET 1: 1455 NW LEARY WAY, SUITE 400
CITY: SEATTLE
STATE: WA
ZIP: 98107
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Anebulo Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001815974
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 851170950
STATE OF INCORPORATION: DE
FISCAL YEAR END: 0630
BUSINESS ADDRESS:
STREET 1: JFL CAPITAL MANAGEMENT
STREET 2: 1017 RR 620 S, SUITE 107
CITY: LAKEWAY
STATE: TX
ZIP: 78734
BUSINESS PHONE: 737 203 5270
MAIL ADDRESS:
STREET 1: JFL CAPITAL MANAGEMENT
STREET 2: 1017 RR 620 S, SUITE 107
CITY: LAKEWAY
STATE: TX
ZIP: 78734
4
1
doc4.xml
FORM 4 SUBMISSION
X0508
4
2023-11-13
0
0001815974
Anebulo Pharmaceuticals, Inc.
ANEB
0001770436
English Aron R.
C/O ANEBULO PHARMACEUTICALS, INC.
1017 RANCH ROAD 620 SOUTH, SUITE 107
LAKEWAY
TX
78734
1
0
1
0
0001694297
22NW, LP
590 1ST AVE S UNIT C-1
SEATTLE
WA
98104
0
0
1
0
0001640809
22NW Fund, LP
590 1ST AVE S UNIT C-1
SEATTLE
WA
98104
0
0
1
0
0
Common Stock
2023-11-13
4
A
0
300000
0.00
A
300000
I
22NW, LP
Common Stock
2023-12-18
4
G
0
300000
0.00
D
0
I
22NW, LP
Common Stock
2023-12-18
4
G
0
300000
0.00
A
5366290
I
22NW Fund, LP
Common Stock
4654528
I
Pharma Investors, LLC
The shares were issued to 22NW, LP as partial consideration for entering into a loan and security agreement with the Issuer.
This Form 4 is filed jointly by Aron R. English, 22NW, LP and 22NW Fund, LP (collectively, the "Reporting Persons"). Each of the Reporting Persons may be deemed to be a member of a Section 13(d) group that collectively beneficially owns more than 10% of the Issuer's outstanding shares of Common Stock. Each of the Reporting Persons disclaims beneficial ownership of the securities of the Issuer owned directly by other members of the Section 13(d) group and this report shall not be deemed an admission that the Reporting Persons are the beneficial owners of such securities for purposes of Section 16 or for any other purpose. Further, each of the Reporting Persons expressly disclaims beneficial ownership of the securities reported herein except to the extent of his or its pecuniary interest therein.
Securities owned directly by 22NW, LP. Mr. English, as the Manager of 22NW, LP may be deemed to beneficially own the securities owned directly by 22NW, LP.
Securities owned directly by 22NW Fund, LP. Mr. English, as the Manager of 22NW Fund GP, LLC, which is the General Partner of 22NW Fund, LP, may be deemed to beneficially own the securities owned directly by 22NW Fund, LP.
Securities owned directly by Pharma Investors, LLC. Mr. English, as the owner of Pharma Investors, LLC, may be deemed to beneficially own the securities owned directly by Pharma Investors, LLC.
/s/ Aron R. English
2023-12-20
22NW, LP; By: 22NW GP, Inc.; By: /s/ Aron R. English, President and Sole Shareholder
2023-12-20
22NW Fund, L.P.; By: 22 NW Fund GP, LLC; By /s/ Aron R. English
2023-12-20